We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$5.92M
Cap. Flow
-$8.98M
Cap. Flow %
-4.32%
Top 10 Hldgs %
59.09%
Holding
74
New
5
Increased
12
Reduced
47
Closed
3

Top Buys

Rank Stock Value
1
TLGT
Teligent, Inc
TLGT
+$4.66M
2
OCLR
Oclaro Inc.
OCLR
+$835K
3
RKUS
RUCKUS WIRELESS INC COM STK (DE)
RKUS
+$813K
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$511K
5
VTSS
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
+$397K

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$5.56M
2
AMTX icon
Aemetis
AMTX
+$1.26M
3
SWKS icon
Skyworks Solutions
SWKS
+$1.2M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$973K
5
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$904K

Sector Composition

Rank Sector Weight
1 Technology 39.91%
2 Healthcare 33.72%
3 Miscellaneous 14.53%
4 Consumer Staples 4.09%
5 Financials 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTSS
1
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
$21.7M 10.42%
5,733,449
+115,408
+2% +$397K
FNSR
2
DELISTED
Finisar Corp
FNSR
$19.1M 9.17%
982,789
-28,357
-3% -$486K
OCLR
3
DELISTED
Oclaro Inc.
OCLR
$18.5M 8.91%
10,415,966
+496,406
+5% +$835K
EMKR
4
DELISTED
Emcore Corp
EMKR
$16.3M 7.84%
307,561
+2,025
+0.7% +$107K
TLGT
5
DELISTED
Teligent, Inc
TLGT
$11.3M 5.44%
128,667
+49,681
+63% +$4.66M
SRGA
6
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$8.45M 4.06%
54,151
-6,274
-10% -$904K
SCON
7
DELISTED
Superconductor Technologies Inc.
SCON
$7.32M 3.52%
1,762
+17
+1% +$71K
PTX
8
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$7.12M 3.42%
75,823
-3,643
-5% -$348K
NEO icon
9
NeoGenomics
NEO
$2.39B
$6.64M 3.19%
1,592,832
-18,300
-1% -$84.1K
STKL
10
DELISTED
SunOpta
STKL
$6.49M 3.12%
547,221
-50,061
-8% -$627K
OMCL icon
11
Omnicell
OMCL
$1.52B
$5.08M 2.44%
153,523
-8,435
-5% -$261K
SUPN icon
12
Supernus Pharmaceuticals
SUPN
$2.57B
$5.02M 2.42%
605,245
-115,820
-16% -$973K
AKRX
13
DELISTED
Akorn Inc
AKRX
$4.8M 2.31%
132,614
-8,079
-6% -$312K
ATRC icon
14
AtriCure
ATRC
$2.51B
$4M 1.92%
200,390
-7,265
-3% -$125K
IDTI
15
DELISTED
Integrated Device Technology I
IDTI
$3.75M 1.81%
191,600
-13,975
-7% -$240K
SWKS icon
16
Skyworks Solutions
SWKS
$10.1B
$3.56M 1.71%
48,934
-19,400
-28% -$1.2M
RKUS
17
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$3.3M 1.58%
274,153
+67,205
+32% +$813K
ALU
18
DELISTED
Alcatel-Lucent
ALU
$2.93M 1.41%
826,374
-236,147
-22% -$736K
ENZ
19
DELISTED
Enzo Biochem, Inc.
ENZ
$2.88M 1.39%
649,400
-10,220
-2% -$48.7K
ARRY
20
DELISTED
Array Biopharma Inc
ARRY
$2.84M 1.36%
600,057
-1,405,353
-70% -$5.56M
ANGO icon
21
AngioDynamics
ANGO
$652M
$2.73M 1.31%
143,468
-15,820
-10% -$268K
PODD icon
22
Insulet
PODD
$9.95B
$2.35M 1.13%
51,065
-4,965
-9% -$212K
KFX
23
DELISTED
KOFAX LIMITED COM STK
KFX
$2.12M 1.02%
301,548
-22,870
-7% -$151K
CTCT
24
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$2.07M 0.99%
56,328
-2,275
-4% -$74.6K
EXTR icon
25
Extreme Networks
EXTR
$3.03B
$1.94M 0.93%
550,027
-77,655
-12% -$284K
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Kopp Investment Advisors held 74 positions worth $208M, up 2.9% from $202M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Kopp Investment Advisors withdrew a net $8.98M in Q4 2014, closing 3 positions and reducing 47 holdings. Its most notable exit was Aemetis, an estimated $1.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Kopp Investment Advisors opened a new position in iShares Russell 2000 Growth ETF worth $537K.

  • Kopp Investment Advisors's largest Q4 2014 buy was iShares Russell 2000 Growth ETF: 3,775 shares worth $537K.
  • Kopp Investment Advisors added most to Teligent, Inc in Q4 2014, an estimated $4.66M increase.
  • Kopp Investment Advisors's biggest Q4 2014 reduction was Array Biopharma Inc, cutting an estimated $5.56M.
  • Kopp Investment Advisors fully exited Aemetis in Q4 2014, selling an estimated $1.26M.
  • Kopp Investment Advisors's ten largest holdings make up 59% of its $208M portfolio in Q4 2014.
  • Kopp Investment Advisors opened 5 new positions and closed 3 in Q4 2014.
  • Kopp Investment Advisors's portfolio value rose 2.9% quarter-over-quarter to $208M.

Based on Kopp Investment Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.